At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
FamPALcarebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coaching End-of-Life Palliative Care for End-Stage Heart Failure Patients and Their Family Caregivers in Rural Appalachia
In Brief
A clinical study evaluating FamPALcare for Heart Failure NYHA Class III and Heart Failure NYHA Class IV. Completed, enrolled 78 participants across 1 site.
Detailed Summary
Overall objective is to test whether the 5-weekly family home palliative and end-of-life care (FamPALcare) intervention educational and supportive sessions will improve rural home end-of-life and palliative care (EOLPC) for advanced heart failure at 6 months follow up.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartJan 2020
Primary CompletionJul 2023
Study CompletionSep 2023
TodayJul 2026
First PostedNov 6, 2019
Enrollment StartJan 13, 2020
Primary CompletionJul 31, 2023
Study CompletionSep 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.7 years ago
Interventions
FamPALcarebehavioral
Intervention participants will receive standard care plus five weekly coaching sessions with telephone follow-up to reinforce HF palliative home care.